(NASDAQ:TMCI), PONTE VEDRA, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) — Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced plans to host an investor day at 9:00 am E.T. on September 3, 2025, in […]
(NasdaqGM:CMPO), Operating results exceed expectations across all key metrics Strong top line growth driven by domestic programs from traditional banks and fintechs Record profitability demonstrates early results from CompoSecure Operating System Raising previously issued full-year 2025 guidance SOMERSET, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) — CompoSecure, Inc. (Nasdaq: CMPO), a leader in metal payment cards,
(NASDAQ:SGMO), Announced positive topline results from registrational STAAR study in Fabry disease, including positive mean annualized estimated glomerular filtration rate (eGFR) slope at 52-weeks across all dosed patients in the study, which U.S. Food and Drug Administration (FDA) has agreed will serve as primary basis of approval. First clinical site initiated for Phase 1/2 STAND
(TSX:SEC), MONTREAL, Aug. 07, 2025 (GLOBE NEWSWIRE) — Senvest Capital Inc. today reported net income attributable to common shareholders of $226.3 million or $92.75 per share for the three months ended June 30, 2025. This compares to a net loss attributable to common shareholders of ($71.7) million or ($29.02) per share for the same period
(NASDAQ:LZ), Solid execution with second quarter revenue exceeding high end of outlook range Second quarter revenue of $192.5 million, up 9% year-over-year Subscription revenue of $119.9 million, an increase of 10% year-over-year, reflecting outstretched progress in initiatives to grow subscription business Second quarter net loss of $0.3 million, compared to net income of $1.3 million
(NYSE MKT:STXS), ST. LOUIS, Aug. 07, 2025 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the second quarter ended June 30, 2025. “We are pleased with our commercial results in the quarter. Sequential and year-over-year growth in both recurring
(NYSE MKT:OZ), SARASOTA, FL, Aug. 07, 2025 (GLOBE NEWSWIRE) — Belpointe PREP, LLC (“Belpointe OZ,” “we,” “us,” “our” or the “Company”), the first and only publicly traded Qualified Opportunity Fund (NYSE American: OZ), is proud to announce that its flagship development, Aster & Links, has been named a Grand Award Winner in two categories at
(NASDAQ:OPRX), Q2 revenue of $29.2 million, increased 55% year-over-year Q2 gross profit increased 59% year-over-year to $18.6 million Paid down $4.5 million of principal on outstanding term loan during Q2 Increased full year 2025 guidance to a revenue range between $104 million and $108 million and adjusted EBITDA range between $14.5 million and $17.5 million
(NasdaqGM:SKYE), Reiterate top-line data readout from CBeyond(TM) Phase 2a study of nimacimab planned late Q3/early Q4 2025 Patient enrollment in Skye's CBeyondTM Phase 2a obesity trial extension study initiated Independent Data Safety Monitoring Committee completed fourth unblinded review with no concerns raised; CBeyondTM study continues per protocol New preclinical study highlights superior weight rebound profile
EXP's Expansion marks first milestone by joining SR 400 Peach Partners in financial close of Georgia SR 400 Express Lanes Project GlobeNewswire August 07, 2025 ATLANTA, Aug. 07, 2025 (GLOBE NEWSWIRE) — EXP, a global engineering, architecture, design and consulting firm, recently established a new infrastructure sector led by business development leader and Senior Vice